NIH-INDIA » National Institutes of Health (NIH) News Releases » Drug halts organ damage in inflammatory genetic disorder

Feeds

1491 items (1491 unread) in 2 feeds

NIH (699 unread)

• National Institutes of Health (NIH) News Releases (699 unread)

TED (792 unread)

• TEDTalks (video) (792 unread)

National Institutes of Health (NIH) News Releases

• February 10, 2012
• 

  Drug halts organ damage in inflammatory genetic disorder

  Posted: February 10th, 2012, 9:50am EST

  Tags:    [edit]

  A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage. The research was performed by scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health.